Clinical trial NCT01095731 - References

Aneurysmal Subarachnoid Hemorrhage — The Effects of Tiopronin on 3-Aminopropanal Level & Neurologic Outcome After Aneurysmal Subarachnoid Hemorrhage

Citation(s)

•   Cockroft KM, Meistrell M 3rd, Zimmerman GA, Risucci D, Bloom O, Cerami A, Tracey KJ
  Cerebroprotective effects of aminoguanidine in a rodent model of stroke. Stroke. 1996 Aug;27(8):1393-8.
•   Dogan A, Rao AM, Hatcher J, Rao VL, Baskaya MK, Dempsey RJ
  Effects of MDL 72527, a specific inhibitor of polyamine oxidase, on brain edema, ischemic injury volume, and tissue polyamine levels in rats after temporary middle cerebral artery occlusion. J Neurochem. 1999 Feb;72(2):765-70.
•   Fisher CM, Kistler JP, Davis JM
  Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery. 1980 Jan;6(1):1-9.
•   Hop JW, Rinkel GJ, Algra A, van Gijn J
  Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review. Stroke. 1997 Mar;28(3):660-4. Review.
•   Ivanova S, Batliwalla F, Mocco J, Kiss S, Huang J, Mack W, Coon A, Eaton JW, Al-Abed Y, Gregersen PK, Shohami E, Connolly ES Jr, Tracey KJ
  Neuroprotection in cerebral ischemia by neutralization of 3-aminopropanal. Proc Natl Acad Sci U S A. 2002 Apr 16;99(8):5579-84. Epub 2002 Apr 9.
•   Ivanova S, Botchkina GI, Al-Abed Y, Meistrell M 3rd, Batliwalla F, Dubinsky JM, Iadecola C, Wang H, Gregersen PK, Eaton JW, Tracey KJ
  Cerebral ischemia enhances polyamine oxidation: identification of enzymatically formed 3-aminopropanal as an endogenous mediator of neuronal and glial cell death. J Exp Med. 1998 Jul 20;188(2):327-40.
•   Kassell NF, Sasaki T, Colohan AR, Nazar G
  Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke. 1985 Jul-Aug;16(4):562-72. Review.
•   Lindell A, Denneberg T, Hellgren E, Jeppsson JO, Tiselius HG
  Clinical course and cystine stone formation during tiopronin treatment. Urol Res. 1995;23(2):111-7.
•   Linn FH, Rinkel GJ, Algra A, van Gijn J
  Incidence of subarachnoid hemorrhage: role of region, year, and rate of computed tomography: a meta-analysis. Stroke. 1996 Apr;27(4):625-9.
•   Mayer S, Kreiter K
  Quality of life after subarachnoid hemorrhage. J Neurosurg. 2002 Sep;97(3):741-2; author reply 742.
•   Seiler N
  Polyamine oxidase, properties and functions. Prog Brain Res. 1995;106:333-44. Review.
•   Shohami E, Nates JL, Glantz L, Trembovler V, Shapira Y, Bachrach U
  Changes in brain polyamine levels following head injury. Exp Neurol. 1992 Aug;117(2):189-95.
•   Solenski NJ, Haley EC Jr, Kassell NF, Kongable G, Germanson T, Truskowski L, Torner JC
  Medical complications of aneurysmal subarachnoid hemorrhage: a report of the multicenter, cooperative aneurysm study. Participants of the Multicenter Cooperative Aneurysm Study. Crit Care Med. 1995 Jun;23(6):1007-17.
•   Wood PL, Khan MA, Moskal JR, Todd KG, Tanay VA, Baker G
  Aldehyde load in ischemia-reperfusion brain injury: neuroprotection by neutralization of reactive aldehydes with phenelzine. Brain Res. 2006 Nov 29;1122(1):184-90. Epub 2006 Oct 5.
•   Wood PL, Khan MA, Moskal JR
  Neurochemical analysis of amino acids, polyamines and carboxylic acids: GC-MS quantitation of tBDMS derivatives using ammonia positive chemical ionization. J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Feb 2;831(1-2):313-9. Epub 2006 Jan 10.

Phase II Study of the Effects of Tiopronin on 3-Aminopropanal Level & Neurologic Outcome After Aneurysmal Subarachnoid Hemorrhage

Details for clinical trial NCT01095731